Nonselective Versus Selective Angioembolization for Trauma Patients with Pelvic Injuries Accompanied by Hemorrhage: A Meta-Analysis
Overview
Affiliations
: Angioembolization has emerged as an effective therapeutic approach for pelvic hemorrhages; however, its exact effect size concerning the level of embolized artery remains uncertain. Therefore, we conducted this systematic review and meta-analysis to investigate the effect size of embolization-related pelvic complications after nonselective angioembolization compared to that after selective angioembolization in patients with pelvic injury accompanying hemorrhage. : Relevant articles were collected by searching the PubMed, EMBASE, and Cochrane databases until 24 June 2023. Meta-analyses were conducted using odds ratios (ORs) for binary outcomes. Quality assessment was conducted using the risk of bias tool in non-randomized studies of interventions. : Five studies examining 357 patients were included in the meta-analysis. Embolization-related pelvic complications did not significantly differ between patients with nonselective and selective angioembolization (OR 1.581, 95% confidence interval [CI] 0.592 to 4.225, I = 0%). However, in-hospital mortality was more likely to be higher in the nonselective group (OR 2.232, 95% CI 1.014 to 4.913, I = 0%) than in the selective group. In the quality assessment, two studies were found to have a moderate risk of bias, whereas two studies exhibited a serious risk of bias. : Despite the favorable outcomes observed with nonselective angioembolization concerning embolization-related pelvic complications, determining the exact effect sizes was limited owing to the significant risk of bias and heterogeneity. Nonetheless, the low incidence of ischemic pelvic complications appears to be a promising result.
Jeong S, Kim D, Kang W PLoS One. 2025; 20(2):e0303476.
PMID: 39913430 PMC: 11801638. DOI: 10.1371/journal.pone.0303476.
Kwon S, Kim K, Jeong S, Kim J, Yeo K, Kwon O J Trauma Inj. 2024; 37(1):28-36.
PMID: 39381149 PMC: 11309153. DOI: 10.20408/jti.2023.0076.
Lee Y, Jeong S, Kim J, Yeo K, Kwon O, Kim K J Trauma Inj. 2024; 37(1):20-27.
PMID: 39381145 PMC: 11309204. DOI: 10.20408/jti.2023.0072.